These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17622486)

  • 1. Safety and efficacy of fractionated stereotactic radiotherapy for acoustic neuromas.
    McClelland S; Gerbi BJ; Higgins PD; Orner JB; Hall WA
    J Neurooncol; 2008 Jan; 86(2):191-4. PubMed ID: 17622486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of a large acoustic tumor with fractionated stereotactic radiotherapy.
    McClelland S; Gerbi BJ; Cho KH; Hall WA
    J Robot Surg; 2007; 1(3):227-30. PubMed ID: 25484968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractionated stereotactic radiotherapy for pituitary adenomas following microsurgical resection: safety and efficacy.
    McClelland S; Higgins PD; Gerbi BJ; Orner JB; Hall WA
    Technol Cancer Res Treat; 2007 Jun; 6(3):177-80. PubMed ID: 17535025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): long-term results in 106 patients treated in a single institution.
    Combs SE; Volk S; Schulz-Ertner D; Huber PE; Thilmann C; Debus J
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):75-81. PubMed ID: 16111574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractionated stereotactic radiotherapy for acoustic neuroma: single-institution experience at The Princess Margaret Hospital.
    Koh ES; Millar BA; Ménard C; Michaels H; Heydarian M; Ladak S; McKinnon S; Rutka JA; Guha A; Pond GR; Laperriere NJ
    Cancer; 2007 Mar; 109(6):1203-10. PubMed ID: 17318817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conventionally fractionated stereotactic radiotherapy (FSRT) for acoustic neuromas.
    Fuss M; Debus J; Lohr F; Huber P; Rhein B; Engenhart-Cabillic R; Wannenmacher M
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1381-7. PubMed ID: 11121637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review.
    Persson O; Bartek J; Shalom NB; Wangerid T; Jakola AS; Förander P
    Acta Neurochir (Wien); 2017 Jun; 159(6):1013-1021. PubMed ID: 28409393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year outcomes following hypofractionated stereotactic radiotherapy delivered in five fractions for acoustic neuromas: the mean cochlear dose may impact hearing preservation.
    Chen Z; Takehana K; Mizowaki T; Uto M; Ogura K; Sakanaka K; Arakawa Y; Mineharu Y; Miyabe Y; Mukumoto N; Miyamoto S; Hiraoka M
    Int J Clin Oncol; 2018 Aug; 23(4):608-614. PubMed ID: 29556918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas.
    Combs SE; Welzel T; Schulz-Ertner D; Huber PE; Debus J
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):193-200. PubMed ID: 19604653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced-dose fractionated stereotactic radiotherapy for acoustic neuromas: maintenance of tumor control with improved hearing preservation.
    Champ CE; Shen X; Shi W; Mayekar SU; Chapman K; Werner-Wasik M; Farrell CJ; Gunn V; Downes MB; Liu H; Evans JJ; Andrews DW
    Neurosurgery; 2013 Sep; 73(3):489-96. PubMed ID: 23756743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionated stereotactic radiotherapy for acoustic neuromas: safety and effectiveness over 8 years of experience.
    Sakanaka K; Mizowaki T; Arakawa Y; Araki N; Oya N; Takahashi JA; Mikuni N; Miyamoto S; Hashimoto N; Hiraoka M
    Int J Clin Oncol; 2011 Feb; 16(1):27-32. PubMed ID: 20830603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy in patients with vestibular schwannoma and neurofibromatosis type 2: clinical results and review of the literature.
    Wagner J; Welzel T; Habermehl D; Debus J; Combs SE
    Tumori; 2014; 100(2):189-94. PubMed ID: 24852864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hearing preservation after radiotherapy for vestibular schwannomas is comparable to hearing deterioration in healthy adults and is accompanied by local tumor control and a highly preserved quality of life (QOL) as patients' self-reported outcome.
    Combs SE; Welzel T; Kessel K; Habermehl D; Rieken S; Schramm O; Debus J
    Radiother Oncol; 2013 Feb; 106(2):175-80. PubMed ID: 23333012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractionated stereotactic radiotherapy for acoustic neuromas: preservation of function versus size.
    Williams JA
    J Clin Neurosci; 2003 Jan; 10(1):48-52. PubMed ID: 12464521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic radiotherapy for the treatment of acoustic neuromas.
    Selch MT; Pedroso A; Lee SP; Solberg TD; Agazaryan N; Cabatan-Awang C; DeSalles AA
    J Neurosurg; 2004 Nov; 101 Suppl 3():362-72. PubMed ID: 15537191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hearing Preservation for Vestibular Schwannomas Treated with Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy.
    Udawatta M; Kwan I; Preet K; Nguyen T; Ong V; Sheppard JP; Duong C; Romiyo P; Lee P; Tenn S; Kaprealian T; Gopen Q; Yang I
    World Neurosurg; 2019 Sep; 129():e303-e310. PubMed ID: 31132496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic radiotherapy for vestibular schwannomas: favorable outcome with minimal toxicity.
    Chan AW; Black P; Ojemann RG; Barker FG; Kooy HM; Lopes VV; McKenna MJ; Shrieve DC; Martuza RL; Loeffler JS
    Neurosurgery; 2005 Jul; 57(1):60-70; discussion 60-70. PubMed ID: 15987541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic radiosurgery and radiotherapy for acoustic neuromas.
    Kalogeridi MA; Kougioumtzopoulou A; Zygogianni A; Kouloulias V
    Neurosurg Rev; 2020 Jun; 43(3):941-949. PubMed ID: 30982152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level.
    van Linge A; van Os R; Hoekstra N; Heijmen B; Stienstra L; Dallenga A; Wolbers J; Mendez Romero A
    Radiat Oncol; 2018 Dec; 13(1):253. PubMed ID: 30583739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractionated stereotactic radiotherapy of vestibular schwannomas accelerates hearing loss.
    Rasmussen R; Claesson M; Stangerup SE; Roed H; Christensen IJ; Cayé-Thomasen P; Juhler M
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e607-11. PubMed ID: 22560549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.